menu
    • menu

    Company profile for Cellarity

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them. Cellarity is using its platform to design medicines targeting the f...
    Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellarityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Technology Sq, Cambridge, Massachusetts 02139
    Telephone
    Telephone
    +1 617 500 7775
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cellarity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cellarity/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellarity Provides Strategic Priorities And Outlook For 2026
    Cellarity Provides Strategic Priorities And Outlook For 2026

    08 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-08/cellarity-provides-strategic-priorities-and-outlook-for-2026

    PHARMIWEB
    08 Jan 2026
    Share Share
    Cellarity To Present At J.P. Morgan Healthcare Conference
    Cellarity To Present At J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105526564/en/Cellarity-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Cellarity Unveils Drug Safety Prediction Framework in Nature
    Cellarity Unveils Drug Safety Prediction Framework in Nature

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113871982/en/Cellarity-Publishes-Groundbreaking-Framework-for-Predicting-Drug-Safety-in-Nature-Communications

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Cellarity Presents Two Oral Sessions at ASH Annual Meeting
    Cellarity Presents Two Oral Sessions at ASH Annual Meeting

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103310587/en/Cellarity-Announces-Two-Oral-Presentations-During-the-67th-American-Society-of-Hematology-Annual-Meeting

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Cellarity Unveils Cell State-Correcting Drug Discovery Framework
    Cellarity Unveils Cell State-Correcting Drug Discovery Framework

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021180543/en/Cellarity-Publishes-Framework-for-Discovery-of-Cell-State-Correcting-Medicines-in-Science

    BUSINESSWIRE
    23 Oct 2025
    Share Share
    Cellarity Initiates Phase 1 Clinical Study of CLY-124
    Cellarity Initiates Phase 1 Clinical Study of CLY-124

    26 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cellarity-initiates-phase-1-clinical-study-of-cly-124-a-first-in-class-globin-switching-oral-medicine-for-the-treatment-of-sickle-cell-disease-302492168.html

    PR NEWSWIRE
    26 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search